SGRP vs SRPT · rev $67.4M vs rev $1.13B
SPAR Group Inc (SGRP) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
SPAR Group Inc (SGRP) is a specialty business services company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SGRP revenue for 2026-06-30 was $67.4M. Net income was -$144.0K. SGRP currently screens at market cap $22.7M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
SGRP currently screens at market cap $22.7M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the SGRP and SRPT stock pages for the full models.
Not investment advice.